Christian Gonzalez, MD
Pain Medicine · Aventura, FLNPI 1912987983
Payments from drug & device makers
Across 920 payments — averaging $48.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$16K
- Biotronik NRO, Inc.$12K
- Medtronic$3K
- Vertos Medical, Inc.$3K
- Spinal Simplicity, LLC$2K
- Vertiflex, Inc.$2K
- plus $7K from 51 others
What the payments were for
- Consulting fees$4,0049%
- Speaking & faculty fees$1,8004%
- Travel & lodging$2,5566%
- Food & beverage$34,84578%
- Education$1,5063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$4,842
- Prospera$4,042
- mild Device Kit$2,217
- PROCLAIM$2,199
- HA MINUTEMAN G3-R$1,714
- Superion ISS$1,568
- SCS IPGs$892
- Proclaim IPG$590
- INTELLIS ADAPTIVESTIM$489
- KYPHON EXPRESS II KYPHOPAK TRAY$352
- ETERNA$285
- SUPERION$278
- KYPHON Balloon Kyphoplasty$249
- Roxybond$216
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$208
- INTELLIS$152
- Nalu Neurostimulation System$125
- Intracept$125
- UBRELVY$123
- MONOVISC$120
How this compares
$44,710 in reported general payments places this provider in the 90th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 115 | $265,464 |
| OxycontinOxycodone Hcl | 199 | $162,871 |
| Xtampza ErOxycodone Myristate | 152 | $152,436 |
| RoxybondOxycodone Hcl | 55 | $98,239 |
| MovantikNaloxegol Oxalate | 227 | $95,621 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,850 | $80,104 |
| RayosPrednisone | 18 | $73,192 |
| Nurtec OdtRimegepant Sulfate | 30 | $54,479 |
| ZtlidoLidocaine | 67 | $49,175 |
| Oxycodone Hcl | 1,431 | $36,691 |
| Fentanyl | 153 | $23,292 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 720 | $20,971 |
| LinzessLinaclotide | 39 | $20,829 |
| NalocetOxycodone Hcl/Acetaminophen | 11 | $17,783 |
| Pregabalin | 475 | $13,643 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $738 | $265,464115 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $341 | $165,584169 claims |
| Protega Pharmaceutials IncRoxybond | $369 | $98,23955 claims |
| Redhill Biopharma Inc.Movantik | $424 | $95,621227 claims |
| AmgenRayos | $30 | $73,19218 claims |
| PfizerNurtec Odt | $30 | $54,47930 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $976 | $49,17567 claims |
| AbbVieLinzess | $123 | $20,82939 claims |
| Forte Bio-pharma LLCNalocet | $363 | $17,78311 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate, Buprenorphine | $19 | $10,608178 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Aventura
- Anand PatelOrmond Beach$20.4M
- Julio PaezClermont$2.3M
- Joseph PergolizziNaples$2.1M
- Abel MurilloMiami$1.6M
- George MonluxPalm Coast$1.3M
- Ferdinand FormosoJacksonville$1M
- Cesar LassalleOrlando$1M
- Robert GuirguisTampa$895K
- Ashraf HannaClearwater$608K
- Peter MichaelCoral Gables$496K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.